Last €34.28 EUR
Change Today +0.085 / 0.25%
Volume 0.0
8AK On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 2:07 AM 08/28/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for alkermes plc (8AK)

Currency in
Millions of US Dollars
As of:Mar 31
2010
Reclassified
Mar 31
2011
Reclassified
Mar 31
2012
Reclassified
Dec 31
2013
4 Year
Trend
NET INCOME-39.6-45.5-113.723.5
Depreciation & Amortization25.08.722.543.1
Amortization of Goodwill and Intangible Assets----25.451.2
DEPRECIATION & AMORTIZATION, TOTAL25.08.747.994.4
Asset Writedown & Restructuring Costs----45.8--
Other Operating Activities1.7-3.9-10.2-28.2
Tax Benefit from Stock Options-----4.3-15.2
Change in Accounts Receivable-0.72.3-14.0-12.7
Change in Inventories-4.05.2-4.9-8.5
Change in Accounts Payable-2.17.015.621.5
Change in Unearned Revenues-4.80.66.15.4
Change in Other Working Capital-1.6-0.10.5-1.8
CASH FROM OPERATIONS-12.2-5.9-2.5123.0
Capital Expenditure-15.8-9.4-17.0-25.4
Sale of Property, Plant, and Equipment0.20.40.00.1
Cash Acquisitions-----494.8--
Investments in Marketable & Equity Securities43.514.694.6-61.8
CASH FROM INVESTING28.05.6-417.2-87.2
Long-Term Debt Issued----444.1--
TOTAL DEBT ISSUED----444.1--
Long Term Debt Repaid-23.5-45.4-0.8-6.7
TOTAL DEBT REPAID-23.5-45.4-0.8-6.7
Issuance of Common Stock2.66.220.965.4
Repurchase of Common Stock-2.7------
Other Financing Activities0.2-1.40.7-0.4
CASH FROM FINANCING-23.3-40.7464.858.3
NET CHANGE IN CASH-7.6-40.945.294.1
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
8AK:GR €34.28 EUR +0.085

8AK Competitors

Market data is delayed at least 15 minutes.

Company Last Change
BioMarin Pharmaceutical Inc $70.80 USD -0.75
Cosmo Pharmaceuticals SpA SFr.169.00 CHF -5.50
Impax Laboratories Inc $24.53 USD -0.38
Jazz Pharmaceuticals PLC $163.11 USD -0.45
Pacira Pharmaceuticals Inc/DE $107.13 USD -0.58
View Industry Companies
 

Industry Analysis

8AK

Industry Average

Valuation 8AK Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 11.7x
Price/Book 4.9x
Price/Cash Flow 135.7x
TEV/Sales 10.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALKERMES PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.